American Healthcare REIT Inc (AHR) valuation history

$53.02

Latest weekly close · Market cap $10.3B

Share AHR EV/EBITDA history
Above its usual range

As of

AHR's EV/EBITDA of 14.0x is higher than 83% of its weekly readings since February 2024.

Weekly EV/EBITDA since February 2024

EV/EBITDA each weekMiddle half of its readingsMedian 10.0×
EV/EBITDA weekly history0×5×10×15×20×14.0×202420252026
Median
10.0×
Low to high
1.7×–16.2×
Versus median
+40%
History starts
February 2024

EV/EBITDA

83rdpercentile

of its weekly readings since February 2024

Above its usual range

Growth, last 12 months vs the year before

Revenue
+16%accelerating
EPS
n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading
-1,000-50005001,000202420252026

EV/EBITDA at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

AHR EV/EBITDA at each year-end
Year-endEV/EBITDA5-year percentile
13.5×92
7.0×89

Loading peers and related research…

About this history

What is AHR's current EV/EBITDA?
AHR's EV/EBITDA of 14.0x is higher than 83% of its weekly readings since February 2024.
What is AHR's five-year median EV/EBITDA?
10.0x. Half of AHR's weekly readings since February 2024 were higher and half were lower. This page has 142 weekly readings, from Feb 5, 2024 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?
No. The rank compares AHR only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built